The body’s chemical plant, operated on with respect for its power to heal itself.
The liver can regenerate; the pancreas forgives nothing. HPB surgery is where honest selection matters most — knowing when an operation offers your best chance, and saying so plainly when it does not.
What is HPB cancer?
“HPB” covers the deepest territory of abdominal surgery: the liver (primary tumours and metastatic spread), gallbladder, bile ducts (cholangiocarcinoma) and pancreas. These organs sit tucked beneath the ribcage, wired into major vessels — which is why their cancers often stay quiet until jaundice or pain announces them.
Surgery offers the best chance of cure in this region when it is feasible — but feasibility must be judged honestly. A liver can regrow after two-thirds is removed; a pancreas resection carries genuine risk that deserves respect, not denial. Techniques such as ALPPS and portal vein embolisation exist so that even a small future liver remnant can be grown to a safe size before major resection.
The promise here is honesty first: an operability assessment that tells you the truth — operate now, treat first then operate, or focus on comfort — because each answer is sometimes the right one, and you deserve to know which applies to you.
Eight signals that deserve a specialist’s eyes
These organs whisper late. Any of the following warrants same-week assessment rather than watchful waiting at home.
- ①Yellowing of the eyes or skin (jaundice) appearing without reason.
- ②Persistent itching all over the body, worse at night, without any rash.
- ③Pale, clay-coloured stools.
- ④Unusually dark urine, especially alongside pale stools.
- ⑤Pain in the upper-right abdomen, constant or recurring.
- ⑥Diabetes appearing suddenly in mid-life, particularly with weight loss.
- ⑦Unexplained weight loss with loss of appetite.
- ⑧Fever occurring together with jaundice — this combination needs urgent attention.
Cancers treated in this territory
◆Liver — Primary Tumours
Cancers arising within the liver itself, treated by segment-oriented resection.
◆Liver — Metastatic Disease
Tumours spreading from elsewhere (often bowel) where liver surgery meaningfully extends life.
◆Gallbladder Cancer
An underdiagnosed regional disease — managed with properly radical cholecystectomy.
◆Bile Duct (Cholangiocarcinoma)
Duct tumours causing jaundice, treated with resection and reconstruction of drainage.
◆Pancreas — Head
Whipple-territory tumours requiring complex en-bloc resection.
◆Pancreas — Body & Tail
Lesions approached through distal pancreatectomy, with splenic decisions discussed openly.
Operations performed here
- ◈Segment-oriented liver resectionsRemoving only the involved segments, saving every gram of working liver possible.
- ◈Right / left hepatectomyMajor liver resections planned around the remaining liver’s ability to regenerate.
- ◈Whipple procedure (pancreaticoduodenectomy)The defining pancreatic-head operation, done en-bloc with proper nodal clearance.
- ◈Distal pancreatectomy ± splenectomyFor body-and-tail lesions, with spleen preservation considered where safe.
- ◈Radical cholecystectomyGallbladder cancer treated definitively at the first operation — the one chance that matters.
- ◈Bile duct resection & hepaticojejunostomyRebuilding bile drainage; ALPPS/PVE planning for small remnant livers when needed.
From first visit to full recovery
Honest operability assessment
The first question answered: should this be operated on at all?
Triple-phase imaging
Vessels, segments and future liver volume measured precisely.
Tumour board alignment
Medical and radiation oncology agree on sequence — including therapy-first routes.
Surgery
Resection balancing complete clearance against remnant safety.
Regeneration watch
Liver function monitored closely as the remaining liver grows into its new job.
Long-term surveillance
Scheduled scans and markers for years — not just weeks.
Families usually ask…
It is major surgery and should never be described otherwise. But modern segment-oriented technique, careful remnant-volume planning and experienced postoperative care have transformed its safety. The honest conversation is about whether your liver and your tumour make it the right choice.
Yes — uniquely among human organs, the liver regenerates. Up to two-thirds can be removed, and the remainder grows back over weeks. When the future remnant starts too small, two-stage strategies like PVE or ALPPS can grow it to a safe size first.
Because the pancreas sits against critical vessels and leaks matter when it heals badly. Outcomes depend heavily on surgeon volume and preparation. It also means patients deserve honest counselling about risks and alternatives — which is exactly how these decisions are made here.
No. Jaundice has many causes, including stones and infections. But every new jaundice needs prompt, systematic evaluation — same-week assessment — because if something serious is present, time matters enormously.
For some liver and pancreatic cancers, treating first shrinks the tumour, controls hidden disease, and makes the eventual operation safer or even possible when it was not before. The board decides based on evidence — not on the convenience of going straight to theatre.